FDA approves Moderna's mRNA flu vaccine in public health breakthrough

The US Food and Drug Administration approved Moderna's mRNA-based influenza vaccine, marking a major public health milestone. It is the first time mRNA technology — proven during the COVID-19 pandemic — has been applied to a flu vaccine. The approval came despite the current US administration's sceptical stance on vaccines.